Transmission rates following combinations recommended
in British guidelines were 0.7% (17/2286) for highly active antiretroviral
therapy with planned Caesarean section, 0.7% (4/559) for highly active antiretroviral
therapy with planned vaginal delivery, and 0% (0/464) for zidovudine monotherapy
with planned Caesarean section (P¼0.150)